The Risk of Creating Difficult-To-Treat Psoriasis by Switching Multiple Biologic Therapies: A Case Report and Relative Considerations

Journal Title: Journal of Dermatology Research - Year 2022, Vol 3, Issue 1

Abstract

Despite the revolution represented by biologic drugs, it is safe to say that every dermatologist has known the frustrating experience of treating a “difficult” patient with psoriasis. Such patients may have been treated with numerous drugs, never achieving long-term disease control. We hereby present the case of a patient who, despite having been treated, over the course of 15 years, with 7 biologics and 3 traditional systemic agents, has never experienced lasting remission. We also discuss hypothetical reasons for these repeated treatment failures: while obesity and ANA positivity could have contributed significantly, a third, more complex, factor may be to blame. It is possible that frequently switching to the newest drug available, due to lack of other therapeutic options, interfered with the pathogenetic phenotype of the patient, and, consequently, with the response to other biologics. This disheartening and fascinating hypothesis clearly needs to be investigated, in the hope of finding solutions for all seemingly impossible-to-treat patients.

Authors and Affiliations

Martina Burlando1*, Ilaria Salvi1, Emanuele Cozzani1, Aurora Parodi1

Keywords

Related Articles

Rheumatoid Vasculitis: Heterogeneous Clinical Presentation

Vasculitis is defined as a vascular inflammation which may be localized or systemic and mostly idiopathic. Usually it affects several organs of the body such as skin, kidneys and lungs. Vasculitis is one of the biggest...

Successful Control of Some Challenging Cases in Late Adult and Elderly Onset Atopic Dermatitis with Dupilumab Injection in Kuwaiti Patients: A Prospective Pilot Study

Atopic Dermatitis is severely itchy skin disease with chronic prolonged course and relapsing flares, which was considered mainly infantile or childhood in onset for a long time. Atopic Dermatitis is not any more a pediat...

The Influence of Veganism on Acne

Background: There is an historical controversy regarding the relation of acne and diet. Despite being veganism a current topic, no studies have been yet conducted to assess whether following a vegan diet has a positive o...

The Weight of Traditional Therapy in The Management of Chronic Skin Diseases in Donka National Hospital

Chronic skin diseases affect patients’ physical, psychological and social well-being. They lead patients to seek care in conventional and traditional medicine. The aim of this study was to determine the contributions of...

Interleukin-36 and Generalized Pustular Psoriasis: A Narrative Review of the Role of IL-36 in Generalized Pustular Psoriasis and an Update on Treatments

Generalized Pustular Psoriasis (GPP) is one of the rare variants of Psoriasis vulgaris. It can be life-threatening, especially in pregnant women or in a setting of multiple co-morbidities. The pathophysiology of chronic...

Download PDF file
  • EP ID EP702452
  • DOI http://dx.doi.org/10.46889/JDR.2022.3102
  • Views 38
  • Downloads 0

How To Cite

Martina Burlando1*, Ilaria Salvi1, Emanuele Cozzani1, Aurora Parodi1 (2022). The Risk of Creating Difficult-To-Treat Psoriasis by Switching Multiple Biologic Therapies: A Case Report and Relative Considerations. Journal of Dermatology Research, 3(1), -. https://europub.co.uk/articles/-A-702452